Abstract
Refined kenaf seed oil was microencapsulated by spray drying using the wall materials of β-cyclodextrin (β-CD), gum arabic (GA), and sodium caseinate (SC) to produce three different models (SC:β-CD, GA:β-CD, GA:SC:β-CD) of microencapsulated refined kenaf seed oil (MRKSO). An in-vitro digestion was used to simulate the human gastrointestinal digestion to examine the oil release behavior of MRKSO, changes in antioxidant activity and bioactive compounds of undigested oil, digested oil, and digested MRKSO samples. The results showed that three models of the MRKSO offered good protection by a lower percentage of oil released (1.43–6.44%) in the simulated gastric fluid and a high percentage of oil released (81.10–91.19%) after simulated gastric and intestinal phases digestion. The degree of lipolysis was in the order of SC:β-CD > GA:SC:β-CD > GA:β-CD > un-encapsulated oil. Among three models of MRKSO, GA:SC:β-CD offered better bioaccessibility by showing an increase in DPPH (20.0% increase) and ABTS (5.0% increase) values, phenolic content (130.4% increase), tocopherol and tocotrienol contents (147.7% increase), as well as slower degradation of phytosterol contents (59.4% decrease) after in-vitro digestion, compared to the undigested kenaf seed oil.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
